Tag: Drug Prices

California Aims To Tackle Health Care Prices In Novel Rate-Setting Proposal | California Healthline

California Aims To Tackle Health Care Prices In Novel Rate-Setting Proposal | California Healthline

Backed by labor and consumer groups, a California lawmaker unveiled a proposal Monday calling for the state to set health care prices in the commercial insurance market. Supporters of the legislation, called the Health Care Price Relief Act, say California has made major strides in expanding health insurance coverage, but recent changes haven’t addressed the […]

Sanofi to Start Offering Discounts on Two Insulin Products | AJMC.com

Sanofi to Start Offering Discounts on Two Insulin Products | AJMC.com

The discount to patients comes as Sanofi, Eli Lilly, and Novo Nordisk are parties in a racketeering lawsuit where they recently acknowledged that consumers’ sticker shock over insulin prices are real. It’s just not the manufacturers’ fault, they argue, and it’s definitely not a crime. “Defendants acknowledge that pharmaceutical pricing is an important issue, especially […]

CVS Health Kept Drug Price Growth Nearly Flat and Improved Medication Adherence for PBM Clients in | CVSHealth

CVS Health Kept Drug Price Growth Nearly Flat and Improved Medication Adherence for PBM Clients in | CVSHealth

Although manufacturer-driven price inflation for specialty drugs measured 8.3 percent in 2017, CVS Health was able to keep specialty drug cost growth at just 3.7 percent for clients. This was achieved through effective formulary strategies, indication- and outcomes-based contracting and cost-cap based rebates. CVS Health also offers PBM clients a variety of formulary strategies, which […]

Price Transparency Strategy Needs Improvement | MedScape

Price Transparency Strategy Needs Improvement | MedScape

Although patients support healthcare price shopping in theory, few are doing it, dampening hopes that price transparency alone will drive down escalating healthcare costs, say authors of a health policy report published online April 4 in the New England Journal of Medicine. Ateev Mehrotra, MD, MPH, from Harvard Medical School, Boston, Massachusetts, and colleagues note […]

PhRMA argues early notice of price hikes won’t benefit patients | BioPharma Dive

PhRMA argues early notice of price hikes won’t benefit patients | BioPharma Dive

Dive Brief: Informing payers of looming drug price hikes hurts patients much more than it helps, industry trade group PhRMA argued in a blog post published last week. The post comes as a growing number of states are considering and passing legislation aimed at making drug pricing decisions more transparent. California’s State Bill 17 is […]

Teva, Valeant price-hike plans trigger warnings under California’s new transparency law: report | FiercePharma

Teva, Valeant price-hike plans trigger warnings under California’s new transparency law: report | FiercePharma

California is among a group of states that have taken drug prices into their own hands, with lawmakers last year passing a bill aimed at shining new light on the pricing process. Now, the state is starting to see early results. Documents obtained by Politico show that Valeant Pharmaceuticals plans a 63% price hike on a generic glaucoma […]

Aetna Will Apply Pharmacy Rebates to Prescription Drugs in 2019 | HealthPayer Intelligence

Aetna Will Apply Pharmacy Rebates to Prescription Drugs in 2019 | HealthPayer Intelligence

“We have always believed that consumers should benefit from discounts and rebates that we negotiate with drug manufacturers,” said Mark T. Bertolini, Aetna chairman and CEO. “Going forward, we hope this additional transparency will encourage these companies to rationalize their pricing and end the practice of annual double-digit price increases.” Aetna believes that improving prescription […]

Drug middlemen clash with FDA over blame for high prices | Washington Examiner

Drug middlemen clash with FDA over blame for high prices | Washington Examiner

“Contrary to today’s remarks, pharmacy benefit managers have long been strong supporters of bipartisan legislation that would prevent brand drug manufacturer abuses of risk evaluation and mitigation strategies that block generic competition,” according to a statement from the PBM group Pharmaceutical Care Management Association. The Campaign for Sustainable Rx Pricing, an advocacy group that has […]

Trump’s Health Secretary Wants To Transform Healthcare. Can He? | Forbes

Trump’s Health Secretary Wants To Transform Healthcare. Can He? | Forbes

Reduce Hospital Costs Recent acts of Congress have accelerated the growth of hospital monopolies. Medicare Accountable Care Organizations–created through provisions in Obamacare—have encouraged hospital systems to buy up private practices in ways that expand hospitals’ market power and lead to higher prices. Azar has the ability to revise the ACO rules, and other Medicare regulations, […]

We Must Hold Big Pharma Accountable For Predatory Pricing | HuffPost

We Must Hold Big Pharma Accountable For Predatory Pricing | HuffPost

Big Pharma is pushing every scheme imaginable to squeeze money from the pockets of patients who need insulin to survive. Many with diabetes, faced with tripling insulin prices ($200 to $700 per month), are now forced to choose between life and rent. Some patients ― like 26-year-old Alec Raeshawn Smith, who aged out of his […]